These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 8930007

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J, Barkin RL.
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A risk-benefit assessment of mirtazapine in the treatment of depression.
    Kasper S, Praschak-Rieder N, Tauscher J, Wolf R.
    Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
    [Abstract] [Full Text] [Related]

  • 7. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
    Davis R, Wilde MI.
    CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Safety of mirtazapine: a review.
    Montgomery SA.
    Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():37-45. PubMed ID: 8930008
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of mirtazapine in clinically relevant subgroups of depressed patients.
    Nutt DJ.
    Depress Anxiety; 1998 Dec; 7 Suppl 1():7-10. PubMed ID: 9597345
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD.
    J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
    [Abstract] [Full Text] [Related]

  • 13. A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients.
    Høyberg OJ, Maragakis B, Mullin J, Norum D, Stordall E, Ekdahl P, Ose E, Moksnes KM, Sennef C.
    Acta Psychiatr Scand; 1996 Mar; 93(3):184-90. PubMed ID: 8739664
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K, Søgaard J, Martin S, Bäuml J, Ravindran AV, Agren H, Vester-Blokland ED.
    J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
    [Abstract] [Full Text] [Related]

  • 17. Mirtazapine: a review of its use in major depression.
    Holm KJ, Markham A.
    Drugs; 1999 Apr; 57(4):607-31. PubMed ID: 10235695
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
    Smith WT, Glaudin V, Panagides J, Gilvary E.
    Psychopharmacol Bull; 1990 Apr; 26(2):191-6. PubMed ID: 2236455
    [Abstract] [Full Text] [Related]

  • 20. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.
    Wheatley DP, van Moffaert M, Timmerman L, Kremer CM.
    J Clin Psychiatry; 1998 Jun; 59(6):306-12. PubMed ID: 9671343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.